IT Management

With pharma companies adopting an increasing number of digital tools, proper IT management and security is more critical than ever. Our coverage includes the latest in validation and implementation as well as trends in the ever-evolving landscape for IT systems.

Articles

PM2206-HERO-575x327-Automation
PM2206-HERO-575x327-Automation
PM2206-HERO-575x327-Automation
PM2206-HERO-575x327-Automation
PM2206-HERO-575x327-Automation

Circling back to digital initiatives in pharma

Three priorities for re-strategizing digital transformation post-COVID
PM2205-HERO-575x327-Culture2
PM2205-HERO-575x327-Culture2
PM2205-HERO-575x327-Culture2
PM2205-HERO-575x327-Culture2
PM2205-HERO-575x327-Culture2

Digitize to curb staffing challenges

Modern manufacturing solutions can spare pharma the worst of ongoing labor shortages
PM2112-HERO-575x327-Automation
PM2112-HERO-575x327-Automation
PM2112-HERO-575x327-Automation
PM2112-HERO-575x327-Automation
PM2112-HERO-575x327-Automation

Value from data: The key to digitization success

Advanced analytics speed time to insight, increasing return on investment
shutterstock-1097969882
shutterstock-1097969882
shutterstock-1097969882
shutterstock-1097969882
shutterstock-1097969882

Cyber experts warn of a new, sophisticated threat targeting pharma

The cyber risk to pharma manufacturers is very real and very current
PM2109-HERO-575x327-Development
PM2109-HERO-575x327-Development
PM2109-HERO-575x327-Development
PM2109-HERO-575x327-Development
PM2109-HERO-575x327-Development

Slow rush to the cloud

Strategic cloud deployment is critical to achieving business and operational result
PM2109-HERO-575x327-CoverStory
PM2109-HERO-575x327-CoverStory
PM2109-HERO-575x327-CoverStory
PM2109-HERO-575x327-CoverStory
PM2109-HERO-575x327-CoverStory

Cyber scares

The threats are real — and criminals are preying on pharma
hero-image
hero-image
hero-image
hero-image
hero-image

Exploring IoT-powered telemetry in pharma cold chains

How incorporating IoT and telematics can prevent supply chain failures
Hero-July-Column
Hero-July-Column
Hero-July-Column
Hero-July-Column
Hero-July-Column

Pharma's smooth transitions

Technology advances are music to the industry's ear
PM2008-HERO-880x500-CoverStory3
PM2008-HERO-880x500-CoverStory3
PM2008-HERO-880x500-CoverStory3
PM2008-HERO-880x500-CoverStory3
PM2008-HERO-880x500-CoverStory3

Pharma finds its digital groove

An upbeat outlook mixed with better technology puts transformation back on track
Screen-Shot-2020-02-17-at-1.32.53-PM
Screen-Shot-2020-02-17-at-1.32.53-PM
Screen-Shot-2020-02-17-at-1.32.53-PM
Screen-Shot-2020-02-17-at-1.32.53-PM
Screen-Shot-2020-02-17-at-1.32.53-PM

Product Focus: The data fix

Innovative digital tools to enhance manufacturing performance
Screen-Shot-2019-12-02-at-12.04.13-PM
Screen-Shot-2019-12-02-at-12.04.13-PM
Screen-Shot-2019-12-02-at-12.04.13-PM
Screen-Shot-2019-12-02-at-12.04.13-PM
Screen-Shot-2019-12-02-at-12.04.13-PM

The crux of an effective pharma recall

Pharma can take steps now to prepare for the interconnected, digital supply chain
Screen-Shot-2019-11-01-at-12.15.21-PM
Screen-Shot-2019-11-01-at-12.15.21-PM
Screen-Shot-2019-11-01-at-12.15.21-PM
Screen-Shot-2019-11-01-at-12.15.21-PM
Screen-Shot-2019-11-01-at-12.15.21-PM

Product Focus: Manufacturing meets Industry 4.0

From increased connectivity throughout operations to better data analysis and automation tools, vendors have innovated solutions to transform every stage of production.
Screen-Shot-2019-10-28-at-12.44.34-PM
Screen-Shot-2019-10-28-at-12.44.34-PM
Screen-Shot-2019-10-28-at-12.44.34-PM
Screen-Shot-2019-10-28-at-12.44.34-PM
Screen-Shot-2019-10-28-at-12.44.34-PM

Evolving risks in continuous manufacturing

Making the switch to continuous creates new challenges for risk management and insurance coverage
Screen-Shot-2019-10-02-at-11.16.14-AM
Screen-Shot-2019-10-02-at-11.16.14-AM
Screen-Shot-2019-10-02-at-11.16.14-AM
Screen-Shot-2019-10-02-at-11.16.14-AM
Screen-Shot-2019-10-02-at-11.16.14-AM

Pharma's 2019 Influential Women in Manufacturing

Two standout industry leaders from this year's class of honorees
data2
data2
data2
data2
data2

How Novartis’ data manipulation case is a cautionary tale for transparency

“Seeing something and saying something” can be applied to the life sciences when a lack of transparency could result in a company facing stiff regulatory action.